Cargando…

Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal human cancers. Transforming Growth Factor Beta (TGF-β) is a cytokine that switches from a tumor-suppressor at early stages to a tumor promoter in the late stages of tumor development, by yet unknown mechanisms. Tumor associated MUC1 is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bose, Mukulika, Grover, Priyanka, Sanders, Alexa J., Zhou, Ru, Ahmad, Mohammad, Shwartz, Sophia, Lala, Priyanka, Nath, Sritama, Yazdanifar, Mahboubeh, Brouwer, Cory, Mukherjee, Pinku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883581/ https://www.ncbi.nlm.nih.gov/pubmed/35237602 http://dx.doi.org/10.3389/fcell.2022.821875

Ejemplares similares

Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma
por: Yazdanifar, Mahboubeh, et al.
Publicado: (2019)

Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models
por: Sahraei, Mahnaz, et al.
Publicado: (2021)

SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line
por: Grover, Priyanka, et al.
Publicado: (2018)

Potential of Anti-MUC1 Antibodies as a Targeted Therapy for Gastrointestinal Cancers
por: Bose, Mukulika, et al.
Publicado: (2020)

A Novel Association of Neuropilin-1 and MUC1 in Pancreatic Ductal Adenocarcinoma: Role in Induction of VEGF Signaling and Angiogenesis
por: Zhou, Ru, et al.
Publicado: (2016)

Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice
por: Curry, Jennifer M., et al.
Publicado: (2019)

Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer
por: Nath, Sritama, et al.
Publicado: (2015)

CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
por: Zhou, Ru, et al.
Publicado: (2019)

Role of Microbiome in Modulating Immune Responses in Cancer
por: Bose, Mukulika, et al.
Publicado: (2019)

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
por: Zhou, Ru, et al.
Publicado: (2020)

Mucin signature as a potential tool to predict susceptibility to COVID‐19
por: Bose, Mukulika, et al.
Publicado: (2020)

Reply to the letter from Dr. Pirjo Pärnänen et al
por: Bose, Mukulika, et al.
Publicado: (2021)

MUC1 Regulates PDGFA Expression During Pancreatic Cancer Progression
por: Sahraei, Mahnaz, et al.
Publicado: (2012)

Pancreatic Cancer Cells Isolated from Muc1-Null Tumors Favor the Generation of a Mature Less Suppressive MDSC Population
por: Kidiyoor, Amritha, et al.
Publicado: (2014)

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
por: Roy, Lopamudra Das, et al.
Publicado: (2010)

Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles
por: Wu, Shu-ta, et al.
Publicado: (2018)

Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors()()
por: Moore, Laura Jeffords, et al.
Publicado: (2016)

Expression of MUC1, MUC2 and MUC5AC in salivary gland mucoepidermoid carcinoma: A case series with diagnostic implications
por: Sood, Neelam, et al.
Publicado: (2022)

Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004
por: Wu, Shu-ta, et al.
Publicado: (2018)

Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma
por: Dréau, Didier, et al.
Publicado: (2019)

Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas
por: Do, Sung-Im, et al.
Publicado: (2013)

Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
por: Yokoyama, Seiya, et al.
Publicado: (2016)

Overcoming the UCB HSCs –Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways
por: Shokouhifar, Alireza, et al.
Publicado: (2021)

MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
por: Nath, S, et al.
Publicado: (2013)

Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes
por: Pathangey, Latha B., et al.
Publicado: (2016)

LeishIF3d is a non-canonical cap-binding protein in Leishmania
por: Bose, Priyanka, et al.
Publicado: (2023)

Preclinical evaluation of an (111)In/(225)Ac theranostic targeting transformed MUC1 for triple negative breast cancer
por: Kelly, Vanessa J, et al.
Publicado: (2020)

MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas
por: Luan, Zhou, et al.
Publicado: (2021)

Understanding the Clinical Impact of MUC5AC Expression on Pancreatic Ductal Adenocarcinoma
por: Manne, Ashish, et al.
Publicado: (2021)

Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review
por: Slepicka, Priscila Ferreira, et al.
Publicado: (2021)

Differential Expression and Diagnostic Value of MUC5AC Glycoforms in Pancreatic Ductal Adenocarcinoma
por: Manne, Ashish, et al.
Publicado: (2023)

Canonical and Non-canonical TGFβ Signaling Activate Autophagy in an ULK1-Dependent Manner
por: Trelford, Charles B., et al.
Publicado: (2021)

γδ T Cells: The Ideal Tool for Cancer Immunotherapy
por: Yazdanifar, Mahboubeh, et al.
Publicado: (2020)

Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4
por: Gál, Eleonóra, et al.
Publicado: (2020)

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice
por: Lakshminarayanan, Vani, et al.
Publicado: (2016)

Stereoselective Syntheses of 3′-Hydroxyamino- and 3′-Methoxyamino-2′,3′-Dideoxynucleosides
por: Bose, Sritama, et al.
Publicado: (2019)

MUC13 Interaction with Receptor Tyrosine Kinase HER2 Drives Pancreatic Ductal Adenocarcinoma Progression
por: Khan, Sheema, et al.
Publicado: (2016)

MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism
por: Muniyan, Sakthivel, et al.
Publicado: (2016)

Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
por: Morandi, Fabio, et al.
Publicado: (2020)

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r03e79ttv7d5t2uuf8ebiihcha